Michael Powell, Director at Orexigen Therapeutics, Inc. (OREX), sold 30,800 shares at $12.05 ($371K) on 2008-08-27, disclosed to the SEC on 2008-08-29.
Open-market sale of $371k OREX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.05 | 200 | $2K | 0.6% |
| 2 | $12.05 | 3,300 | $40K | 10.7% |
| 3 | $12.05 | 16,500 | $199K | 53.6% |
| 4 | $12.05 | 100 | $1K | 0.3% |
| 5 | $12.05 | 1,800 | $22K | 5.8% |
| 6 | $12.05 | 8,900 |
| $107K |
| 28.9% |
| Total | $12.05 avg | 30,800 | $371K | 100% |
| Filing → |
| OCRX | SELL | 2016-12-30 | $15K | — | Filing → |
| MIRN | BUY | 2015-10-06 | $6.0M | — | Filing → |
| AERI | SELL | 2014-07-11 | $24.2M | — | Filing → |